By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Crown Bioscience, Inc. 

4008 Burton Drive

Santa Clara  California  95054  U.S.A.
Phone: 617-818-2285 Fax: 408-986-0019

Crown Bioscience, Inc. is a premium biology CRO, providing discovery and early development solutions for global biotech and pharmaceutical companies. It is headquartered in the Silicon Valley, with wholly owned research centers in Beijing, China and Indianapolis. Crown Bioscience is the leader in providing high-quality and cost-effective services in preclinical oncology. Our services include target protein expression, purification and crystallization, in vitro/in vivo pharmacology, non-GLP toxicology, PK/PD, and translational research with patient-derived cell lines and animal models.

For more information, please visit our web site at

Key Statistics

Ownership: Private

Web Site: Crown Bioscience, Inc.



Company News
Crown Bioscience, Inc. Launching OncoExpress Technology At ASCO Meeting 5/24/2016 8:52:59 AM
Crown Bioscience, Inc. Launches HuScreen A New High Throughput Service Platform Utilizing The Largest Available Collection Of PDX Models 5/19/2016 10:05:20 AM
Crown Bioscience, Inc. Announces The Establishment Of Unique EGFR-Mutated Non-Small Cell Lung Cancer Models 5/10/2016 6:50:21 AM
Crown Bioscience, Inc. Launches MuScreen Platform For Evaluating In Vivo Efficacy Of Immuno-Oncology Agents 4/26/2016 8:08:07 AM
Crown Bioscience, Inc. To Showcase Scientific Expertise At AACR 4/12/2016 7:36:20 AM
Crown Bioscience, Inc. Strengthens Immuno-oncology Capabilities With HuGEMM 4/5/2016 10:24:31 AM
Crown Bioscience, Inc. Licenses Its HuBase PDX Management Software 3/29/2016 9:43:26 AM
Crown Bioscience, Inc. Acquires PreClinOmics, Expands Cardiovascular and Metabolic Disease Portfolio 3/8/2016 10:36:21 AM
Crown Bioscience, Inc. To Commercialize University of York’s Prostate Cancer Models For Drug Development 2/11/2016 9:24:36 AM
Crown Bioscience, Inc. To Hold Symposium On Precision Medicine And Translating Oncology Drug Discovery Into Success In The Clinic 1/28/2016 9:47:17 AM